Infectious Diseases

During the sixth wave, some are asking. Take our poll. See what your colleagues say.

A new study from the Research Institute of the McGill University Health Centre (RI-MUHC) confirms the benefits of fluvoxamine in preventing the risk of hospitalization following a COVID-19 infection.

The drug, named Evusheld, is intended for people who cannot receive a typical vaccine or for whom vaccines alone won't provide enough immunity.

Dr. Robert Dickson found himself reminded recently of the importance of knowing the limits of one’s medical care.

Those who might need the drug the most would do well to learn ahead of time how they might access it, the country's chief public health officer said this week.

The usual viruses that cause infectious hepatitis were not found in the cases, and scientists and doctors are considering other possible causes.

Days after the province's top doctor said Ontario might see up to 600 patients in intensive care during the ongoing sixth wave, hospitals say they're already feeling pressure as a result of staff absences due to the virus.

Starting Monday, those aged 70 and older can get the second booster shot, along with those 50 and older who live in First Nations communities.